These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock. Calandra T; Baumgartner JD; Glauser MP Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of patients with septic shock by endotoxin antibodies]. Fomsgaard A; Baek L Ugeskr Laeger; 1987 Aug; 149(34):2248-52. PubMed ID: 3451447 [No Abstract] [Full Text] [Related]
5. Changes in anti-endotoxin-IgG antibody and endotoxaemia in three cases of gram-negative septic shock. Barclay GR; Scott BB; Wright IH; Rogers PN; Smith DG; Poxton IR Circ Shock; 1989 Oct; 29(2):93-106. PubMed ID: 2582583 [TBL] [Abstract][Full Text] [Related]
12. Treatment of septic shock with immunotherapy. Smith AL Pharmacotherapy; 1998; 18(3):565-80. PubMed ID: 9620107 [TBL] [Abstract][Full Text] [Related]
13. Endotoxin as a therapeutic target in septic shock. Corriveau CC; Danner RL Infect Agents Dis; 1993 Feb; 2(1):35-43. PubMed ID: 8162352 [TBL] [Abstract][Full Text] [Related]
16. [Monoclonal antibodies in the treatment of sepsis and septic shock]. Torrabadella de Reynoso P; Salgado Remigio A; Peracaula Picart R Med Clin (Barc); 1992 Dec; 99(20):784-92. PubMed ID: 1460952 [No Abstract] [Full Text] [Related]
17. [Monoclonal antibodies in the treatment of septic shock]. Trilla A; Alonso P Med Clin (Barc); 1992 Dec; 99(20):778-80. PubMed ID: 1460950 [No Abstract] [Full Text] [Related]
18. Therapies for sepsis. Emerging therapies for sepsis and septic shock. Abraham E West J Med; 1997 Mar; 166(3):195-200. PubMed ID: 9143195 [No Abstract] [Full Text] [Related]